NCT00692848

Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source

The Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 384 (actual)
• Sponsor: St. Justine's Hospital · Academic / Other
• Sex: All
• Age: 1 Month – 36 Months
• Healthy volunteers: Not accepted

Summary

Serious bacterial infections are often difficult to detect in children with fever without source. Procalcitonin is a better blood marker of infection than White blood cell count and possibly than C-reactive protein. This could lead to a reduction in antibiotic prescription. Our objective is to evaluate the impact of Procalcitonin result on antibiotic prescription in children 1 to 36 month old with fever without source and our hypothesis is that it will lower the antibiotic prescription rate

Conditions

• Procalcitonin
• Fever Without Source
• Bacterial Infection
• Bacteremia

Interventions

Type	Name	Description
OTHER	Procalcitonin dosage PCT-Q test (Brahms, Germany)	Procalcitonin result available to the attending physician

Timeline

• Start date: 2006-11-01
• Primary completion: 2007-11-01
• Completion: 2008-06-01
• First posted: 2008-06-06
• Last updated: 2008-06-06

Locations

1 site across 1 country: Canada